Young-Sik Cho
Chairman chez BIONOTE, INC.
Fortune : 981 M $ au 31/03/2024
Profil
Le Dr Young-Sik Cho est directeur de BioNote, Inc. Il est membre du conseil d'administration de SD Biosensor, Inc. Le Dr. Cho était auparavant employé en tant que directeur général par Abbott Diagnostics Korea, Inc. Il a obtenu son doctorat à l'université nationale de Séoul.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
SD BIOSENSOR, INC.
65,23% | 28/03/2024 | 81 198 713 ( 65,23% ) | 712 M $ | 31/03/2024 |
BIONOTE, INC.
60,06% | 26/12/2023 | 61 248 000 ( 60,06% ) | 196 M $ | 31/03/2024 |
EUBIOLOGICS CO., LTD.
18,43% | 11/04/2024 | 6 719 153 ( 18,43% ) | 60 M $ | 31/03/2024 |
CTC BIO INC.
8,70% | 26/12/2023 | 2 103 798 ( 8,70% ) | 14 M $ | 31/03/2024 |
Postes actifs de Young-Sik Cho
| Sociétés | Poste | Début |
|---|---|---|
| BIONOTE, INC. | Chairman | 01/03/2023 |
| SD BIOSENSOR, INC | Chairman | - |
Anciens postes connus de Young-Sik Cho
| Sociétés | Poste | Fin |
|---|---|---|
Abbott Diagnostics Korea, Inc.
 Abbott Diagnostics Korea, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics Korea, Inc. develops diagnostic systems for the detection of infectious diseases. Its products include rapid test kits, human immunodeficiency virus rapid test kits, blood glucose test kits, urine test kits, dengue and rapid dengue test kits, malaria rapid test kits and various forms of enzyme-linked immunosorbent assay kits. The company was founded on February 1, 1999 and is headquartered in Yongin, South Korea. | Chief Executive Officer | - |
Formation de Young-Sik Cho
| Seoul National University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIONOTE, INC. | Health Technology |
| SD BIOSENSOR, INC | Electronic Technology |
| Entreprise privées | 1 |
|---|---|
Abbott Diagnostics Korea, Inc.
Abbott Diagnostics Korea, Inc. Medical SpecialtiesHealth Technology Abbott Diagnostics Korea, Inc. develops diagnostic systems for the detection of infectious diseases. Its products include rapid test kits, human immunodeficiency virus rapid test kits, blood glucose test kits, urine test kits, dengue and rapid dengue test kits, malaria rapid test kits and various forms of enzyme-linked immunosorbent assay kits. The company was founded on February 1, 1999 and is headquartered in Yongin, South Korea. | Health Technology |
